Prospective Evaluation of the Prognostic Implications of Improved Assay Performance With a Sensitive Assay for Cardiac Troponin I

Journal of the American College of Cardiology

Volumn 55, Issue 19, 2010, Pages 2118-2124

  Bonaca, Marc ^a   Scirica, Benjamin ^a   Sabatine, Marc ^a   Dalby, Anthony ^b   Spinar, Jindrich ^c   Murphy, Sabina A ^a   Jarolim, Peter ^a   Braunwald, Eugene ^a   Morrow, David A ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b South African Cardiology Clinical Trials Group   (South Africa)

^c University Hospital St Ann   (Czech Republic)

Author keywords

ACS; acute coronary syndrome; prognosis; sensitive; troponin

Indexed keywords

CREATINE KINASE MB; FIBRINOGEN RECEPTOR ANTAGONIST; PLACEBO; RANOLAZINE; THIENOPYRIDINE DERIVATIVE; TROPONIN I;

ACUTE CORONARY SYNDROME; ADULT; ADVERSE OUTCOME; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; HEART INFARCTION; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; SENSITIVITY AND SPECIFICITY;

ACETANILIDES; ACUTE CORONARY SYNDROME; AGED; BIOLOGICAL MARKERS; ENZYME INHIBITORS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PIPERAZINES; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; TROPONIN I;

EID: 77951631125     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2010.01.044     Document Type: Article

References (30)

1. Jaffe A.S., Ravkilde J., Roberts R., et al. It's time for a change to a troponin standard. Circulation 102 (2000) 1216-1220
2. Anderson J.L., Adams C.D., Antman E.M., et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction). J Am Coll Cardiol 50 (2007) e1-e157
3. Morrow D.A., Cannon C.P., Jesse R.L., et al. National Academy of Clinical Biochemistry laboratory medicine practice guidelines: clinical characteristics and utilization of biochemical markers in acute coronary syndromes. Clin Chem 53 (2007) 552-574
4. Antman E.M., Tanasijevic M.J., Thompson B., et al. Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. N Engl J Med 335 (1996) 1342-1349
5. Heidenreich P.A., Alloggiamento T., Melsop K., McDonald K.M., Go A.S., and Hlatky M.A. The prognostic value of troponin in patients with non-ST elevation acute coronary syndromes: a meta-analysis. J Am Coll Cardiol 38 (2001) 478-485
6. James S.K., Armstrong P., Barnathan E., et al. Troponin and C-reactive protein have different relations to subsequent mortality and myocardial infarction after acute coronary syndrome: a GUSTO-IV substudy. J Am Coll Cardiol 41 (2003) 916-924
7. Thygesen K., Alpert J.S., White H.D., et al. Universal definition of myocardial infarction. Circulation 116 (2007) 2634-2653
8. Keller T., Zeller T., Peetz D., et al. Sensitive troponin I assay in early diagnosis of acute myocardial infarction. N Engl J Med 361 (2009) 868-877
9. Reichlin T., Hochholzer W., Bassetti S., et al. Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. N Engl J Med 361 (2009) 858-867
10. Melanson S.E., Morrow D.A., and Jarolim P. Earlier detection of myocardial injury in a preliminary evaluation using a new troponin I assay with improved sensitivity. Am J Clin Pathol 128 (2007) 282-286
11. Apple F.S., Smith S.W., Pearce L.A., Ler R., and Murakami M.M. Use of the Centaur TnI-ultra assay for detection of myocardial infarction and adverse events in patients presenting with symptoms suggestive of acute coronary syndrome. Clin Chem 54 (2008) 723-728
12. Melanson S.E., Conrad M.J., Mosammaparast N., and Jarolim P. Implementation of a highly sensitive cardiac troponin I assay: test volumes, positivity rates and interpretation of results. Clin Chim Acta 395 (2008) 57-61
13. Morrow D.A. Clinical application of sensitive troponin assays. N Engl J Med 361 (2009) 913-915
14. Morrow D.A., Scirica B.M., Karwatowska-Prokopczuk E., et al. Effects of ranolazine on recurrent cardiovascular events in patients with non-ST-elevation acute coronary syndromes: the MERLIN-TIMI 36 randomized trial. JAMA 297 (2007) 1775-1783
15. Morrow D.A., Scirica B.M., Karwatowska-Prokopczuk E., et al. Evaluation of a novel anti-ischemic agent in acute coronary syndromes: design and rationale for the metabolic efficiency with ranolazine for less ischemia in non-ST-elevation acute coronary syndromes (MERLIN)-TIMI 36 trial. Am Heart J 151 (2006) 1186.e1-1186.e9
16. Antman E.M., Cohen M., Bernink P.J., et al. The TIMI risk score for unstable angina/non-ST elevation MI: a method for prognostication and therapeutic decision making. JAMA 284 (2000) 835-842
17. Pencina M.J., D'Agostino Sr. R.B., D'Agostino Jr. R.B., and Vasan R.S. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 27 (2008) 157-172 discussion 207-12
18. Morrow D.A., Antman E.M., Tanasijevic M., et al. Cardiac troponin I for stratification of early outcomes and the efficacy of enoxaparin in unstable angina: a TIMI-11B substudy. J Am Coll Cardiol 36 (2000) 1812-1817
19. Kontos M.C., Shah R., Fritz L.M., et al. Implication of different cardiac troponin I levels for clinical outcomes and prognosis of acute chest pain patients. J Am Coll Cardiol 43 (2004) 958-965
20. Wu A.H., Fukushima N., Puskas R., Todd J., and Goix P. Development and preliminary clinical validation of a high sensitivity assay for cardiac troponin using a capillary flow (single molecule) fluorescence detector. Clin Chem 52 (2006) 2157-2159
21. Sabatine M.S., Morrow D.A., de Lemos J.A., Jarolim P., and Braunwald E. Detection of acute changes in circulating troponin in the setting of transient stress test-induced myocardial ischaemia using an ultrasensitive assay: results from TIMI 35. Eur Heart J 30 (2009) 162-169
22. Apple F.S., Smith S.W., Pearce L.A., and Murakami M.M. Assessment of the multiple-biomarker approach for diagnosis of myocardial infarction in patients presenting with symptoms suggestive of acute coronary syndrome. Clin Chem 55 (2009) 93-100
23. Wu A.H., Agee S.J., Lu Q.A., Todd J., and Jaffe A.S. Specificity of a high-sensitivity cardiac troponin I assay using single-molecule-counting technology. Clin Chem 55 (2009) 196-198
24. Morrow D.A., and Antman E.M. Evaluation of high-sensitivity assays for cardiac troponin. Clin Chem 55 (2009) 5-8
25. Wilson S.R., Sabatine M.S., Braunwald E., Sloan S., Murphy S.A., and Morrow D.A. Detection of myocardial injury in patients with unstable angina using a novel nanoparticle cardiac troponin I assay: observations from the PROTECT-TIMI 30 trial. Am Heart J 158 (2009) 386-391
26. Schulz O., Kirpal K., Stein J., et al. Importance of low concentrations of cardiac troponins. Clin Chem 52 (2006) 1614-1615
27. Eggers K.M., Jaffe A.S., Lind L., Venge P., and Lindahl B. Value of cardiac troponin I cutoff concentrations below the 99th percentile for clinical decision-making. Clin Chem 55 (2009) 85-92
28. Wallace T.W., Abdullah S.M., Drazner M.H., et al. Prevalence and determinants of troponin T elevation in the general population. Circulation 113 (2006) 1958-1965
29. Zethelius B., Johnston N., and Venge P. Troponin I as a predictor of coronary heart disease and mortality in 70-year-old men: a community-based cohort study. Circulation 113 (2006) 1071-1078
30. Wu A.H., Lu Q.A., Todd J., Moecks J., and Wians F. Short- and long-term biological variation in cardiac troponin I measured with a high-sensitivity assay: implications for clinical practice. Clin Chem 55 (2009) 52-58